NCT07543029 Kangaroo Care: Breastfeeding Success and Maternal Role
| NCT ID | NCT07543029 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Recep Tayyip Erdogan University |
| Condition | Breastfeeding |
| Study Type | INTERVENTIONAL |
| Enrollment | 112 participants |
| Start Date | 2025-06-01 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 112 participants in total. It began in 2025-06-01 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Purpose: This is a randomized controlled trial designed to investigate the effects of Kangaroo Mother Care (KMC) applied in the early postpartum period to primiparous mothers on breastfeeding success and the perception of the maternal role. Methodology and Sample: Setting and Period: The study will be conducted at the Bucak State Hospital Delivery Unit between June 2025 and June 2026. Sample Size: Based on G\*Power analysis (alpha=0.05, power=80%, effect size d=0.566), a total of 112 mothers (56 intervention, 56 control) will be included, accounting for a 10% potential attrition rate. Participants will be assigned to groups using the sealed envelope method and randomization via www.random.org. Intervention: Experimental Group: Following routine care, the newborn will be placed in a "chest-to-chest" position on the mother's bare chest for Kangaroo Care. Intermittent KMC will be maintained for 24 hours, during which breastfeeding attempts will be supported. Control Group: Mothers and newborns will receive only the hospital's routine care (standard skin-to-skin contact and breastfeeding support). Data Collection Tools: Personal Information Form, Semantic Differential Scale-Myself as a Mother (to measure maternal role perception), LATCH Breastfeeding Assessment Tool (to evaluate breastfeeding success).
Eligibility Criteria
Inclusion Criteria: * For mothers: * It must be the mother's first birth, * Birth must have been vaginal, * The mother must be healthy, * The mother must voluntarily participate in the study, * The mother must not have any communication-impairing conditions (language, cognitive problems, etc.), For babies: * Birth weight must be between 2500-4000 grams; * The newborn must be healthy, * Exclusively breastfed, * The newborn must be at term gestation (38-42 weeks), * The newborn's Apgar score at 1 and 5 minutes must be above 7, * The newborn must not have any health problems that could affect breastfeeding (cleft palate, cleft lip, esophageal atresia, etc.). Exclusion Criteria: \-
Contact & Investigator
Gamzegül ALTAY, PhD
PRINCIPAL INVESTIGATOR
Recep Tayyip Erdogan University
Frequently Asked Questions
Who can join the NCT07543029 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 49 Years, studying Breastfeeding. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07543029 currently recruiting?
Yes, NCT07543029 is actively recruiting participants. Contact the research team at gamzegul.altay@erdogan.edu.tr for enrollment information.
Where is the NCT07543029 trial being conducted?
This trial is being conducted at Rize, Turkey (Türkiye).
Who is sponsoring the NCT07543029 clinical trial?
NCT07543029 is sponsored by Recep Tayyip Erdogan University. The principal investigator is Gamzegül ALTAY, PhD at Recep Tayyip Erdogan University. The trial plans to enroll 112 participants.